Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on June 1, 2026

Jun. 1, 2026

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

Indeterminate GlobeNewswire

Jun. 1, 2026

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

LifeMD Appoints Umesh Sripad as Chief Technology Officer

Indeterminate GlobeNewswire

Jun. 1, 2026

NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Jun. 1, 2026

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Solid Biosciences to Participate at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 1, 2026

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

Indeterminate GlobeNewswire

Jun. 1, 2026

Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma

Indeterminate GlobeNewswire

Jun. 1, 2026

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

Indeterminate GlobeNewswire

Jun. 1, 2026

Caring Brands Inc. and SanPellegrino Cosmetics Private Limited Announce Expanded Multi-Territory Licensing Agreement for Photocil and Hair Enzyme Booster

Indeterminate GlobeNewswire

Jun. 1, 2026

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Indeterminate GlobeNewswire

Jun. 1, 2026

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

Indeterminate GlobeNewswire

Jun. 1, 2026

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Indeterminate GlobeNewswire

Jun. 1, 2026

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

Jun. 1, 2026

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

Indeterminate GlobeNewswire

Jun. 1, 2026

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Indeterminate GlobeNewswire

Jun. 1, 2026

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

Indeterminate GlobeNewswire